GDYO enhanced interaction on ITGB2 and MRC2 with mouse plasma protein absorption, and improved the anti-leukemia effect in vitro, which partially revealed the mechanism of effective therapeutic effect in mice AML model. The gene discussed is ITGB2; the disease is acute myeloid leukemia.